Search

Your search keyword '"Proteus drug effects"' showing total 1,511 results

Search Constraints

Start Over You searched for: Descriptor "Proteus drug effects" Remove constraint Descriptor: "Proteus drug effects"
1,511 results on '"Proteus drug effects"'

Search Results

1. Diagnostic ultrasonography and antimicrobial resistance of different pathogens associated with canine and feline lower urinary tract disorders.

2. Abundance of New Delhi Metallo-β-Lactamase-Producing Acinetobacter , Escherichia , Proteus , and Pseudomonas spp. in Mahananda and Karala Rivers of India.

3. Otodectic and bacterial etiology of feline otitis externa in Tripoli, Libya.

4. Synergistic effects of combinatorial chitosan and polyphenol biomolecules on enhanced antibacterial activity of biofunctionalaized silver nanoparticles.

5. High prevalence of multiple drug resistant enteric bacteria: Evidence from a teaching hospital in Southwest Nigeria.

6. Genomic and functional characterization of fecal sample strains of Proteus cibarius carrying two floR antibiotic resistance genes and a multiresistance plasmid-encoded cfr gene.

7. Clinical pharmacokinetics of flomoxef in prostate tissue and dosing considerations for prostatitis based on site-specific pharmacodynamic target attainment.

8. Antimicrobial resistance patterns of urine culture specimens from 27 nursing homes: Impact of a two-year antimicrobial stewardship intervention.

9. Allicin prevents the formation of Proteus-induced urinary crystals and the blockage of catheter in a bladder model in vitro.

10. Incidence of antibiogram, antibiotic resistance genes and class 1 and 2 integrons in tribe Proteeae with IMP27 gene for the first time in Providencia sp. isolated from pet turtles.

11. Prevalence and antimicrobial susceptibility of asymptomatic bacteriuria among women with pelvic organ prolapse in Abakaliki, South-East Nigeria.

12. Synthesis and characterization of hyaluronic acid hydrogels crosslinked using a solvent-free process for potential biomedical applications.

13. Analogues of Disulfides from Allium stipitatum Demonstrate Potent Anti-tubercular Activities through Drug Efflux Pump and Biofilm Inhibition.

14. [Susceptibility to first-generation Cephalosporins in Enterobacteriaceae isolated from urine culture according to CLSI and EUCAST breakpoints].

15. Primary and Secondary Bacteremia Caused by Proteus spp.: Epidemiology, Strains Susceptibility and Biofilm Formation.

16. Urinary pathogenic bacterial profile, antibiogram of isolates and associated risk factors among pregnant women in Ambo town, Central Ethiopia: a cross-sectional study.

17. Complete sequences of qnrD-carrying plasmids in Proteus spp. collected from French animals.

18. A retrospective analysis: do bacterial culture and sensitivity data support empiric use of piperacillin-tazobactam and antipseudomonal fluoroquinolones in hospitalized patients?

20. The Burden of Comorbidity Is Associated with Antibiotic Resistance Among Institutionalized Elderly with Urinary Infection: A Retrospective Cohort Study in a Single Italian Nursing Home Between 2009 and 2014.

21. Pharmacokinetic and pharmacodynamic evaluations of a 10 mg/kg enrofloxacin intramuscular administration in bearded dragons (Pogona vitticeps): a preliminary assessment.

22. Antibiotic Sensitivity pattern of Bacterial Isolates of Neonatal Septicemia in Peshawar, Pakistan.

23. SXT/R391 integrative and conjugative elements in Proteus species reveal abundant genetic diversity and multidrug resistance.

24. Molecular identification of multi drug resistant bacteria from urinary tract infected urine samples.

25. Molecular epidemiology and antimicrobial susceptibility of AmpC- and/or extended-spectrum (ESBL) ß-lactamaseproducing Proteus spp. clinical isolates in Zenica-Doboj Canton, Bosnia and Herzegovina.

26. [The activity of moxalactam against Enterobacteriaceae and anaerobia in vitro].

27. Bacterial resistance in urinary tract infections in patients with diabetes matched with patients without diabetes.

28. Insights into copper effect on Proteus hauseri through proteomic and metabolic analyses.

29. Exploring the Medicinal Potential of the Fruit Bodies of Oyster Mushroom, Pleurotus ostreatus (Agaricomycetes), against Multidrug-Resistant Bacterial Isolates.

30. [ANTIMICROBIAL ACTION OF NOCARDIA VACCINII IMV B-7405 SURFACTANTS].

31. Mass mortality in ornamental fish, Cyprinus carpio koi caused by a bacterial pathogen, Proteus hauseri.

32. Case-control study of the risk factors for acquisition of Pseudomonas and Proteus species during tigecycline therapy.

33. Penetration of piperacillin-tazobactam into human prostate tissue and dosing considerations for prostatitis based on site-specific pharmacokinetics and pharmacodynamics.

34. In vitro bactericidal activity of cefepime and cefpirome against clinical isolates at Karachi.

35. In vitro cytotoxic effects of gold nanoparticles coated with functional acyl homoserine lactone lactonase protein from Bacillus licheniformis and their antibiofilm activity against Proteus species.

36. [THE USE OF PROBIOTICS IN PATIENTS WITH RHEUMATOID ARTHRITIS].

37. Copper response of Proteus hauseri based on proteomic and genetic expression and cell morphology analyses.

38. Efficacy of some colloidal silver preparations and silver salts against Proteus bacteria, one possible cause of rheumatoid arthritis.

39. Anti-Proteus activity of some South African medicinal plants: their potential for the prevention of rheumatoid arthritis.

40. Spectroscopic analysis, DNA binding and antimicrobial activities of metal complexes with phendione and its derivative.

41. [Oflomelid ointment: activity against hospital microbial strains].

42. Surface plasmon resonance optical sensor and antibacterial activities of biosynthesized silver nanoparticles.

43. Resistance pattern of clinical isolates involved in surgical site infections.

44. Antimicrobial activity of extracts from in vivo and in vitro propagated Lamium album L. plants.

45. Comparative evaluations on bio-treatment of hexavalent chromate by resting cells of Pseudochrobactrum sp. and Proteus sp. in wastewater.

46. Antimicrobial activity of Willowherb (Epilobium angustifolium L.) leaves and flowers.

47. Effects of subtherapeutic concentrations of antimicrobials on gene acquisition events in Yersinia, Proteus, Shigella, and Salmonella recipient organisms in isolated ligated intestinal loops of swine.

48. Multidrug-resistant bacterial isolates in infected wounds at Jimma University Specialized Hospital, Ethiopia.

49. Carbapenemase producing Proteus: any therapeutic suggestions?

50. Identification and antibiotic susceptibility of bacterial isolates from dogs with otitis externa in Australia.

Catalog

Books, media, physical & digital resources